ArticleLung cancer (Amsterdam, Netherlands)2017

Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy.

Jie Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.